Evidence map›Paper›PMID 34613767›Full record

ArticleScience advances2021

A GTP-synthesizing ribozyme selected by metabolic coupling to an RNA polymerase ribozyme.

Arvin Akoopie, Joshua T Arriola, Douglas Magde, Ulrich F Müller

Abstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. A GTP synthase ribozyme with increased GTP turnover.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Principles ofJournal of the Royal Society, Interface · 2025
    Article
  7. Evolution of the substrate specificity of an RNA ligase ribozyme from phosphorimidazole to triphosphate activation.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. A ribozyme that uses lanthanides as cofactor.Nucleic acids research · 2023
    Article
  10. Article
  11. In vitro evolution of ribonucleases from expanded genetic alphabets.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Arvin AkoopieDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0001-7833-4172
Joshua T ArriolaDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, USA.
Douglas MagdeDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, USA.
Ulrich F MüllerDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0002-7473-538X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synthesis of RNA in early life forms required chemically activated nucleotides, perhaps in the same form of nucleoside 5′-triphosphates (NTPs) as in the contemporary biosphere. We show the development of a catalytic RNA (ribozyme) that generates the nucleoside triphosphate guanosine 5′-triphosphate (GTP) from the nucleoside guanosine and the prebiotically plausible cyclic trimetaphosphate. Ribozymes were selected from 1.6 × 10

Identifiers

PMID34613767
PMCPMC8494290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.